Ischemic Compression Therapy for Migraine – Effects on Neck Mobility, Headache Relief, and Biochemical Changes

Migraine is more than just a neurological condition—it frequently involves musculoskeletal dysfunction, particularly in the neck and shoulder regions. A large proportion of individuals with migraine (around 70 to 76 percent) report neck pain. This pain is often linked to tight muscles and the presence of myofascial trigger points, especially in the upper trapezius muscle. A study published in BMC Musculoskeletal Disorders investigated how ischemic compression therapy applied to these trigger points affects neck movement, headache symptoms, and levels of a pain-related protein known as calcitonin gene-related peptide.

Study Details

• Participants: The study included 53 women diagnosed with different forms of migraine, including migraine with aura, migraine without aura, and chronic migraine.
• Treatment: Each participant received seven sessions of ischemic compression therapy over approximately 25 days. The therapy targeted key muscles in the neck and shoulder regions that commonly develop trigger points.
• Measurements: Researchers assessed changes in cervical spine movement using motion sensors, recorded self-reported headache intensity, frequency, and duration, and measured blood levels of calcitonin gene-related peptide before and after the therapy.

Main Findings Relevant for Therapists

1. Improved Neck Movement
   • Movement in the neck, especially forward bending and rotation, significantly improved in participants with episodic migraines one month after therapy.
   • For individuals with chronic migraine, side-bending of the neck improved by the end of therapy and continued to improve one month later.
   • These improvements suggest that ischemic compression reduces muscle tightness and improves flexibility and coordination in the cervical spine.
2. Reduced Headache Symptoms
   • Across all forms of migraine, participants experienced a significant decrease in the intensity, frequency, and duration of headache episodes following the treatment.
   • This supports the use of ischemic compression as an effective manual therapy to reduce headache burden in migraine patients.
3. Limited Changes in Pain-Related Protein
   • The protein calcitonin gene-related peptide, which is linked to migraine attacks and increased pain sensitivity, showed no significant change in most participants after therapy.
   • The findings suggest that the benefits of ischemic compression are primarily mechanical and neuromuscular, rather than anti-inflammatory or biochemical in nature.

Clinical Implications for Therapists

• Ischemic compression of myofascial trigger points is a safe, hands-on intervention that can significantly improve neck mobility and relieve headache symptoms in people with migraine.
• Manual identification and treatment of trigger points remain the primary technique, although variability in palpation skill should be noted.
• Improving cervical spine function may reduce adverse tension in surrounding tissues, including the spinal dura, which may contribute to reducing headache symptoms.

Considerations for Practice

• The study included only women, so the results may not apply to men.
• Patients were not permitted to take pain-relieving medications during the study, which may differ from typical clinical settings.
• While ischemic compression did not appear to change inflammatory protein levels significantly, it still produced measurable improvements in neck mobility and headache characteristics.

Takeaway for Therapists
Ischemic compression therapy targeting neck and shoulder muscle trigger points can be a valuable addition to the treatment of migraine. Although it may not alter chemical pain markers in the blood, it effectively improves physical function and reduces headache intensity, frequency, and duration. This therapy should be considered as part of a comprehensive, non-pharmacological approach to managing migraine.

Please visit https://terrarosa.com.au/